302.00
-0.50
(-0.17%)
At close: January 24 at 5:35:10 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
118,641.00
118,641.00
98,984.00
129,904.00
118,918.00
Investing Cash Flow
-121,869.00
-121,869.00
-54,832.00
-51,214.00
339,521.00
Financing Cash Flow
-2,723.00
-2,723.00
-34,755.00
-91,693.00
-349,891.00
End Cash Position
173,358.00
173,358.00
176,679.00
172,136.00
179,567.00
Capital Expenditure
-59,901.00
-59,901.00
-53,577.00
-47,167.00
-28,992.00
Issuance of Debt
88,651.00
88,651.00
85,439.00
65,643.00
44,997.00
Repayment of Debt
-50,492.00
-50,492.00
-96,478.00
-77,984.00
-373,337.00
Free Cash Flow
58,740.00
58,740.00
45,407.00
82,737.00
89,926.00
12/31/2020 - 7/7/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNW2.MU Sanofi SA
49.80
+0.81%
GS71.DE GSK plc
16.26
-0.25%
JNJ.HM Johnson & Johnson
140.08
-1.16%
SAN.PA Sanofi
100.16
+0.27%
AZN.L AstraZeneca PLC
11,050.00
+0.04%
ROG.SW Roche Holding AG
274.90
+0.18%
NOVO-B.CO Novo Nordisk A/S
622.40
+7.13%
MRK Merck & Co., Inc.
95.55
-1.12%
NVO Novo Nordisk A/S
87.97
+8.47%
JNJ Johnson & Johnson
146.82
+0.12%